Ion Beam Applications SA (IOBCF)
16.06
+0.86
(+5.66%)
USD |
OTCM |
Jan 16, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 470.02M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 19.21% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.7254 |
| Price to Book Value | 5.358 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.2772 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 75.36% |
Profile
| Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment include development, fabrication, and services associated with medical and industrial particle accelerators and proton therapy systems. The Dosimetry segment comprises activities that offer a full range of solutions and services that maximize efficiency and minimize errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company was founded by Yves Jongen on March 28, 1986 and is headquartered in Louvain-la-Neuve, Belgium. |
| URL | http://www.iba-worldwide.com |
| Investor Relations URL | N/A |
| HQ State/Province | Brussels Region |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Mar. 27, 2026 |
| Last Earnings Release | Aug. 28, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 18, 2025 |
Ratings
Profile
| Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment include development, fabrication, and services associated with medical and industrial particle accelerators and proton therapy systems. The Dosimetry segment comprises activities that offer a full range of solutions and services that maximize efficiency and minimize errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company was founded by Yves Jongen on March 28, 1986 and is headquartered in Louvain-la-Neuve, Belgium. |
| URL | http://www.iba-worldwide.com |
| Investor Relations URL | N/A |
| HQ State/Province | Brussels Region |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Mar. 27, 2026 |
| Last Earnings Release | Aug. 28, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 18, 2025 |